Developer docs
API playgroundTry for free, no card

Search company profiles

Evoke KYNE

Full company profile

uuid000itcf

Namestring
Evoke KYNE
Legal namestring
Inizio Evoke
Websiteurl
evokekyne.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Evoke KYNE, now operating as Inizio Evoke Comms, is a global health communications agency that delivers insights-driven public relations campaigns, policy programs, and disease education initiatives for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients. The firm was founded in 2009 and is headquartered in Dublin, Ireland, with operational leadership split between North America (Stephanie DeViteri, President) and Europe (Dom Elliston, President), under Group President Maryellen Royle. It is a subsidiary of Inizio, a diversified health communications group, and is integrated with adjacent Inizio Evoke capabilities (e.g., Public Affairs & Policy via Incisive Health). It was recognized among North America's leading healthcare agencies in the MM+M Agency 100 2026 list.

Short descriptiontext

Evoke KYNE (Inizio Evoke Comms) is a global health communications agency delivering insights-driven public relations campaigns and policy programs for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients across North America and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
health communications, public relations agency, biotech communications, pharmaceutical marketing, policy advocacy services
NAICS code2 codes
  • Public Relations Agencies54182
  • Advertising, Public Relations, and Related Services5418
SIC code1 code
  • Services-Advertising Agencies7311
Product category
Health Communications Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Communications Services
TypeProfessional Services
Description

Health communications agency providing strategic public relations campaigns, policy programs, and initiatives to pharmaceutical, biotechnology, medtech, consumer, and non-profit clients.

inizioevoke.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Evoke KYNE (operating as Inizio Evoke Comms) is a global health communications agency that delivers insights-driven public relations campaigns, policy programs, and disease education initiatives for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients. The agency simplifies complex scientific information, engages stakeholders such as healthcare professionals, consumers, advocates, shareholders, and policymakers, and operates specialized practices across data and brand communications, patient advocacy, clinical trials communications, global public health, biotech and life sciences, public affairs, and corporate communications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Inizio Evoke is a single unified service offering — a global, award-winning health communications agency. The core Communications service encompasses multiple specialized areas including Data & Brand Comms, Patient Advocacy & Influencer Engagement, Reputation & Social Impact, Global Public Health & Disease Education, Clinical Trials Comms, Corporate Comms & Employee Engagement, Public Affairs & Policy, and Biotech & Life Sciences. These are service offerings/practice areas within the core communications service, not separate product modules.

Product and service1 record
1Inizio Evoke Comms – Health Communications Services
CategoryHealth Communications Agency Services
Description

Insights-driven public relations campaigns, policy programs, and initiatives that advance health and wellbeing for pharmaceutical, biotechnology, medtech, consumer, and non-profit clients, simplifying complex scientific information and engaging stakeholders across HCPs, consumers, advocates, shareholders, and policymakers.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global public relations network with a dedicated healthcare practice serving pharmaceutical, biotech, and consumer health clients with PR, policy, and patient engagement services. Direct competitor for the same enterprise pharma/biotech client roster.

TypeDirect peer
Description

One of the largest global PR firms with a dedicated Health sector practice serving pharma, biotech, medtech, and consumer health clients on brand, policy, and corporate communications. Direct competitor for enterprise health communications mandates.

TypeDirect peer
Description

Omnicom-owned global PR agency with a strong healthcare practice covering pharma, biotech, and medtech communications. Closely comparable in service mix, client base, and global delivery model.

TypeDirect peer
Description

WPP-owned global health communications and advertising network serving pharma, biotech, and consumer health clients. Direct competitor with broader integrated creative/advertising capabilities layered on top of PR.

TypeDirect peer
Description

Communications arm of Syneos Health offering public relations, medical communications, and patient engagement services to pharma/biotech clients. Direct competitor particularly for clinical trials communications and launch work.

TypeDirect peer
Description

Independent healthcare-focused communications and marketing agency serving pharma, biotech, and consumer health clients. Comparable in mid-size positioning, specialization in health, and integrated data/creative offering.

TypeBroad incumbent
Description

Global health-focused network within Havas offering PR, advertising, and consulting across pharma and consumer health. Broader incumbent with overlapping health communications capabilities but a wider portfolio beyond PR.

TypeBroad incumbent
Description

IPG-owned global health communications network providing advertising, PR, and medical communications to pharma clients. Broad incumbent competing in the same enterprise health communications market.

TypeDirect peer
Description

Specialist healthcare public relations and investor relations firm serving biotech, pharma, and medtech clients. Comparable particularly on biotech communications, IPO support, and corporate positioning mandates.

TypeOthers
Description

Communications technology and earned-media platform serving PR agencies and corporate communications teams. Adjacent ecosystem participant rather than direct competitor; relevant for industry tooling and media distribution that agencies leverage.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evoke KYNE

Health Communications Servicesevokekyne.com

Evoke KYNE (Inizio Evoke Comms) is a global health communications agency delivering insights-driven public relations campaigns and policy programs for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients across North America and Europe.

What Evoke KYNE does

Evoke KYNE, now operating as Inizio Evoke Comms, is a global health communications agency that delivers insights-driven public relations campaigns, policy programs, and disease education initiatives for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients. The firm was founded in 2009 and is headquartered in Dublin, Ireland, with operational leadership split between North America (Stephanie DeViteri, President) and Europe (Dom Elliston, President), under Group President Maryellen Royle. It is a subsidiary of Inizio, a diversified health communications group, and is integrated with adjacent Inizio Evoke capabilities (e.g., Public Affairs & Policy via Incisive Health). It was recognized among North America's leading healthcare agencies in the MM+M Agency 100 2026 list.

Evoke KYNE firmographics

Firmographics
Name
Evoke KYNE
Legal name
Inizio Evoke
Website
https://evokekyne.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Short description
Evoke KYNE (Inizio Evoke Comms) is a global health communications agency delivering insights-driven public relations campaigns and policy programs for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients across North America and Europe.
Ownership category
akta.pro rank

Where Evoke KYNE is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Markets served

Evoke KYNE business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Professional Communications Services: Health communications agency providing strategic public relations campaigns, policy programs, and initiatives to pharmaceutical, biotechnology, medtech, consumer, and non-profit clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Evoke KYNE product offering

Product offering

Core offering

Evoke KYNE (operating as Inizio Evoke Comms) is a global health communications agency that delivers insights-driven public relations campaigns, policy programs, and disease education initiatives for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients. The agency simplifies complex scientific information, engages stakeholders such as healthcare professionals, consumers, advocates, shareholders, and policymakers, and operates specialized practices across data and brand communications, patient advocacy, clinical trials communications, global public health, biotech and life sciences, public affairs, and corporate communications.

Product overview

Inizio Evoke is a single unified service offering — a global, award-winning health communications agency. The core Communications service encompasses multiple specialized areas including Data & Brand Comms, Patient Advocacy & Influencer Engagement, Reputation & Social Impact, Global Public Health & Disease Education, Clinical Trials Comms, Corporate Comms & Employee Engagement, Public Affairs & Policy, and Biotech & Life Sciences. These are service offerings/practice areas within the core communications service, not separate product modules.

Differentiator

Problem solved

Functional benefit

Products and services

  • Inizio Evoke Comms – Health Communications Services Insights-driven public relations campaigns, policy programs, and initiatives that advance health and wellbeing for pharmaceutical, biotechnology, medtech, consumer, and non-profit clients, simplifying complex scientific information and engaging stakeholders across HCPs, consumers, advocates, shareholders, and policymakers.

Companies that use Evoke KYNE

Customer profile

Segments5 records

Ideal customer profiles4 records

Evoke KYNE technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Evoke KYNE partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Evoke KYNE competitors and assessment

Company assessment

Direct peers

  • Weber Shandwick Health: Global public relations network with a dedicated healthcare practice serving pharmaceutical, biotech, and consumer health clients with PR, policy, and patient engagement services. Direct competitor for the same enterprise pharma/biotech client roster.
  • Edelman Health: One of the largest global PR firms with a dedicated Health sector practice serving pharma, biotech, medtech, and consumer health clients on brand, policy, and corporate communications. Direct competitor for enterprise health communications mandates.
  • FleishmanHillard Health: Omnicom-owned global PR agency with a strong healthcare practice covering pharma, biotech, and medtech communications. Closely comparable in service mix, client base, and global delivery model.
  • Ogilvy Health: WPP-owned global health communications and advertising network serving pharma, biotech, and consumer health clients. Direct competitor with broader integrated creative/advertising capabilities layered on top of PR.
  • Syneos Health Communications: Communications arm of Syneos Health offering public relations, medical communications, and patient engagement services to pharma/biotech clients. Direct competitor particularly for clinical trials communications and launch work.
  • Real Chemistry: Independent healthcare-focused communications and marketing agency serving pharma, biotech, and consumer health clients. Comparable in mid-size positioning, specialization in health, and integrated data/creative offering.
  • ICR Healthcare: Specialist healthcare public relations and investor relations firm serving biotech, pharma, and medtech clients. Comparable particularly on biotech communications, IPO support, and corporate positioning mandates.

Broad incumbents

  • Havas Health & You: Global health-focused network within Havas offering PR, advertising, and consulting across pharma and consumer health. Broader incumbent with overlapping health communications capabilities but a wider portfolio beyond PR.
  • McCann Health: IPG-owned global health communications network providing advertising, PR, and medical communications to pharma clients. Broad incumbent competing in the same enterprise health communications market.

Others

  • Cision / PR Newswire Health: Communications technology and earned-media platform serving PR agencies and corporate communications teams. Adjacent ecosystem participant rather than direct competitor; relevant for industry tooling and media distribution that agencies leverage.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Evoke KYNE social profiles

Digital presence

Evoke KYNE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evoke KYNE leadership team

Management profile

Number of profiles

Profiles5 records

Evoke KYNE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evoke KYNE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evoke KYNE

What does Evoke KYNE do?

Evoke KYNE (operating as Inizio Evoke Comms) is a global health communications agency that delivers insights-driven public relations campaigns, policy programs, and disease education initiatives for pharmaceutical, biotechnology, medtech, consumer health, and non-profit clients. The agency simplifies complex scientific information, engages stakeholders such as healthcare professionals, consumers, advocates, shareholders, and policymakers, and operates specialized practices across data and brand communications, patient advocacy, clinical trials communications, global public health, biotech and life sciences, public affairs, and corporate communications.

Is Evoke KYNE a public or private company?

Evoke KYNE is a private company. It is classified as corporate owned and is currently operating.

When was Evoke KYNE founded?

Evoke KYNE was founded in 2009. It employs 101 to 250 people.

Where is Evoke KYNE based?

Evoke KYNE is headquartered in Dublin, Ireland, in the Europe region.

How does Evoke KYNE make money?

One revenue line is on record: professional Communications Services.

Who are Evoke KYNE's main competitors?

Direct peers on record are Weber Shandwick Health, Edelman Health, FleishmanHillard Health, Ogilvy Health, Syneos Health Communications, Real Chemistry and ICR Healthcare. Broad incumbents are Havas Health & You and McCann Health. Cision / PR Newswire Health is listed as an others.

Does Evoke KYNE have an API?

No public API is recorded for Evoke KYNE.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HubsEvoke KYNE Appoints Maureen Byrne to President and Promotes Four Executive LeadersEvoke KYNE appointed Maureen Byrne as president, giving her global leadership over the client portfolio, executive team, and 175 employees. David Kyne will now focus on diversifying global communications offerings, and four executives were promoted to support growth. The agency plans to invest in healthcare expertise and has secured new biopharmaceutical client wins in 2022.HubsEvoke KYNE Promotes Jennifer Gallo to Executive Vice President, Client Engagement and Business DevelopmentEvoke KYNE promoted Jennifer Gallo to Executive Vice President, Client Engagement and Business Development, making her global relationship manager for a major client engagement. The agency also promoted Molly Grodin and Felicity Lang to senior vice president roles and expanded its global team by over 25% in 2021.HubsEvoke KYNE Promotes Colleen Brett to Executive Creative DirectorEvoke KYNE promoted Colleen Brett to Executive Creative Director, where she will lead in-house creative and support new business. She has over 20 years of experience and recently appointed several senior art directors. The agency also hired Brad Wellen as Senior Vice President of Social Strategy.HubsEvoke KYNE Promotes Carolyn Coyle to Executive Vice PresidentEvoke KYNE promoted Carolyn Coyle to Executive Vice President, where she will continue as relationship manager for a hematology, oncology, and immunology client engagement. She will also support new business development and lead training for entry-level team members. The agency also hired over 30 new employees in 2021.HubsEvoke KYNE appoints Chanta’ Stewart to Vice President, Head of Diversity, Equity & InclusionEvoke KYNE promoted Chanta' Stewart to Vice President, Head of Diversity, Equity and Inclusion. She will expand global DE&I initiatives, develop a long-term plan with baseline data and benchmarks, and serve on the Global DE&I Committee. The role reflects the company's commitment to addressing social and healthcare inequities.HubsEvoke KYNE promotes Dante DelVecchio to Senior Vice President, announces additional senior appointmentsEvoke KYNE promoted Dante DelVecchio to Senior Vice President, where he will oversee infectious diseases, vaccines, and immuno-oncology client engagements. The agency also appointed Molly Grodin as Vice President in New York and hired Silje Lier and Christy Loringer as Vice Presidents. The firm continues to grow with open positions.HubsEvoke KYNE Appoints Julie O’Donnell as Executive Vice President, Global Head of DigitalEvoke KYNE appointed Julie O'Donnell as Executive Vice President and Global Head of Digital. She will lead the global digital team and expand the agency's digital practice. O'Donnell joined Evoke KYNE in 2017 and previously led marketing at Lundbeck.